We are live on ! Find out more
SAM

Simplify Asset Management Portfolio holdings

AUM $7.19B
1-Year Est. Return 6.88%
This Fund
S&P 500
This Quarter Est. Return
-0.64%
1 Year Est. Return
+6.88%
3 Year Est. Return
+44.98%
5 Year Est. Return
+50.08%
10 Year Est. Return
–
AUM
$2.02B
AUM Growth
-$122M
Cap. Flow
-$78.6M
Cap. Flow %
-3.88%
Top 10 Hldgs %
86.93%
Holding
129
New
23
Increased
19
Reduced
34
Closed
37

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$144M
2
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$89.6M
3
ARQT icon
Arcutis Biotherapeutics
ARQT
+$8.13M
4
DXCM icon
DexCom
DXCM
+$7.8M
5
RMD icon
ResMed
RMD
+$7.26M

Top Sells

Rank Stock Value
1
MTBA icon
Simplify MBS ETF
MTBA
+$55.3M
2
SCHP icon
Schwab US TIPS ETF
SCHP
+$38.1M
3
JPST icon
JPMorgan Ultra-Short Income ETF
JPST
+$25M
4
SRPT icon
Sarepta Therapeutics
SRPT
+$19.6M
5
ZTS icon
Zoetis
ZTS
+$11.7M

Sector Composition

Rank Sector Weight
1 Healthcare 7.7%
2 Energy 1.16%
3 Industrials 0.75%
4 Consumer Discretionary 0.38%
5 Real Estate 0.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSLL icon
26
Direxion Daily TSLA Bull 2X ETF
TSLL
$3.74B
$5.01M 0.25%
+182,122
New +$3.61M
PHAT icon
27
Phathom Pharmaceuticals
PHAT
$873M
$4.73M 0.23%
581,935
+60,000
+11% +$743K
TMO icon
28
Thermo Fisher Scientific
TMO
$198B
$4.69M 0.23%
9,023
-4,747
-34% -$2.61M
REGN icon
29
Regeneron Pharmaceuticals
REGN
$70.9B
$4.46M 0.22%
6,258
-3,333
-35% -$2.8M
GILD icon
30
Gilead Sciences
GILD
$167B
$4.26M 0.21%
46,167
-50,035
-52% -$4.51M
BTC
31
Grayscale Bitcoin Mini Trust ETF
BTC
$3.4B
$4.16M 0.21%
99,349
+42,103
+74% +$1.55M
SRPT icon
32
Sarepta Therapeutics
SRPT
$1.82B
$3.99M 0.2%
32,779
-160,231
-83% -$19.6M
QIS icon
33
Simplify Multi-QIS Alternative ETF
QIS
$38.7M
$3.98M 0.2%
162,293
+100,258
+162% +$2.45M
CTA icon
34
Simplify Managed Futures Strategy ETF
CTA
$1.57B
$3.92M 0.19%
140,378
+86,260
+159% +$2.34M
RNAM
35
DELISTED
Avidity Biosciences
RNAM
$3.63M 0.18%
125,000
– –
TUA icon
36
Simplify Short Term Treasury Futures Strategy ETF
TUA
$752M
$3.62M 0.18%
170,383
+4,857
+3% +$105K
ARDX icon
37
Ardelyx
ARDX
$1.28B
$3.5M 0.17%
689,364
– –
CI icon
38
Cigna
CI
$74.5B
$3.47M 0.17%
12,551
-8,382
-40% -$2.67M
MMM icon
39
3M
MMM
$83.4B
$3.34M 0.17%
25,871
-13,563
-34% -$1.78M
PRAX icon
40
Praxis Precision Medicines
PRAX
$8.77B
$3.32M 0.16%
+43,085
New +$3.12M
TCRX icon
41
TScan Therapeutics
TCRX
$59.8M
$3.18M 0.16%
1,046,916
– –
ESTA icon
42
Establishment Labs
ESTA
$2.72B
$2.96M 0.15%
64,300
+42,661
+197% +$1.86M
CYPH
43
Cypherpunk Technologies Inc
CYPH
$75.4M
$2.72M 0.13%
946,046
-110,849
-10% -$329K
ABT icon
44
Abbott
ABT
$175B
$2.5M 0.12%
22,079
+7,996
+57% +$924K
CHWY icon
45
Chewy
CHWY
$8.57B
$2.46M 0.12%
73,411
-110,251
-60% -$3.43M
APLT
46
DELISTED
Applied Therapeutics
APLT
$2.41M 0.12%
2,817,505
– –
ABEO icon
47
Abeona Therapeutics
ABEO
$399M
$2.28M 0.11%
408,584
– –
TFX icon
48
Teleflex
TFX
$5.96B
$2.27M 0.11%
12,742
-6,666
-34% -$1.37M
IJR icon
49
iShares Core S&P Small-Cap ETF
IJR
$110B
$2.22M 0.11%
+19,280
New +$2.3M
SNDX icon
50
Syndax Pharmaceuticals
SNDX
$2.02B
$1.95M 0.1%
147,641
+25,456
+21% +$436K
1
2
3 4 5

Similar funds

CFG
Citizens Financial Group Providence, Rhode Island $7.19B AUM 23.93% 1-Year Est. Return
FPP
Findlay Park Partners London, United Kingdom $7.17B AUM 17.27% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
UB
UMB Bank Kansas City, Missouri $7.16B AUM 20.88% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
FPA
First Pacific Advisors El Segundo, California $7.14B AUM 21.51% 1-Year Est. Return
SC
Saturna Capital Bellingham, Washington $7.13B AUM 35.47% 1-Year Est. Return
MNA
Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return

Simplify Asset Management's Q4 2024 Portfolio in Review

As of Q4 2024, Simplify Asset Management held 129 positions worth $2.02B, down 5.7% from $2.15B the previous quarter. Its ten largest holdings account for 87% of the portfolio.

Simplify Asset Management withdrew a net $78.6M in Q4 2024, closing 37 positions and reducing 34 holdings. Its most notable exit was Simplify MBS ETF, an estimated $55.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 7.7% of assets, down from 12% a quarter earlier, followed by Energy and Industrials.

Against the trend, Simplify Asset Management opened a new position in Arcutis Biotherapeutics worth $10.3M.

  • Simplify Asset Management's largest Q4 2024 buy was Arcutis Biotherapeutics: 742,299 shares worth $10.3M.
  • Simplify Asset Management added most to iShares Core S&P 500 ETF in Q4 2024, an estimated $144M increase.
  • Simplify Asset Management's biggest Q4 2024 reduction was Sarepta Therapeutics, cutting an estimated $19.6M.
  • Simplify Asset Management fully exited Simplify MBS ETF in Q4 2024, selling an estimated $55.3M.
  • Simplify Asset Management's ten largest holdings make up 87% of its $2.02B portfolio in Q4 2024.
  • Simplify Asset Management opened 23 new positions and closed 37 in Q4 2024.
  • Simplify Asset Management's portfolio value fell 5.7% quarter-over-quarter to $2.02B.

Based on Simplify Asset Management's 13F filing for Q4 2024, filed 11 Feb 2025.